An October 28 article urged growth investors to buy Celestica (TSX: CLS), but the supplied facts don’t include its reasoning. The headline alone doesn’t show which growth drivers the article cited. Celestica’s latest supplied close was C$401.64, up 8.29% for the day.
Investor takeaway: The buy-case headline is an opinion. The supplied facts don’t explain its rationale or what drove the one-day gain.
C$401.64 close; 8.29% one-day gain
Advertisement
Celestica Inc.
CLS.TO
CLS.TO
Celestica Inc.
WealthAwesomeMarket cap
$53.04B
P/E
28.6x
52W high
$655.50
52W low
$330.79
1W change
-1.80%
Beta
1.32
Analyst Price Targets
Based on analyst covering CLS · as of Oct 29, 2026
Wall Street analysts forecast CLS stock price to rise 44.1% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$606.10
+44.1% Upside
Previously C$669.02 on Oct 28, 2026
Current Price
C$420.54
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CLS's historical volatility
30-Day Vol
75.4%
Annualized
90-Day Vol
82.0%
Annualized
Trend (90d)
-41.2%
Annualized drift
90d Mean
C$363.01
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$400.42 | C$308.73 – C$519.34 |
| 60 trading days | C$381.26 | C$263.93 – C$550.73 |
| 90 trading days | C$363.01 | C$231.37 – C$569.57 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
The quote data show a sharp daily rise alongside a 16.86% decline over the past month. Latest volume was 125,436 shares. That’s below the 20-day average of 457,625, despite a separate claim that volume was 2.10 times average. The figures don’t support that comparison.
Bull case
The supplied fundamentals include a 30.2% return on equity and a 6.8% profit margin. October 27 headlines also refer to a Q3 earnings beat and a raised 2026 outlook, but detailed results and guidance figures aren’t provided.
Bear case
Celestica’s share price fell 16.86% over the past month and closed below its 50-day and 200-day moving averages. The supplied facts don’t show whether the October 28 article addressed those declines.
What happened: an opinion headline, not a company announcement
The October 28 end-of-day headline read, “Here is Why Growth Investors Should Buy Celestica (CLS) Now.” It presents a positive investment view, but the supplied facts don’t include the article’s reasoning or evidence, or a new company announcement tied to it.
Separate October 27 headlines refer to a Q3 earnings beat on strong CCS demand and a raised 2026 outlook. They provide background only: no earnings figures, outlook details, or link to the October 28 opinion are included. Visit the Celestica stock page.
What the numbers show: a daily rise amid a monthly decline
Advertisement
Celestica’s supplied last close was C$401.64, up 8.29% for the day, down 1.80% for the week, and down 16.86% for the month. Its year-to-date return was positive 1.41%.
The close was below the supplied 50-day moving average of C$455.76 and 200-day average of C$462.16. These figures describe recent price history, not the reason for the October 28 headline. Celestica’s 52-week range was C$330.79 to C$655.50, and the close was at 22% of that range.
Latest volume was 125,436 shares, compared with a 20-day average of 457,625. The separate claim that volume was 2.10 times average doesn’t match those figures. Supplied fundamentals include a P/E of 28.5887, a 6.8% profit margin, 30.2% ROE, and trailing EPS of 14.71. See the CLS.TO stock page for more company information.
What to watch next: the missing rationale and outlook details
The key question is what evidence the October 28 article used to support its growth-investor view. That rationale isn’t included in the supplied facts. The October 27 headlines make Q3 results, CCS demand, and the raised 2026 outlook relevant context, but the underlying figures and guidance aren’t provided. Without them, this information alone isn’t enough to assess the headline against Celestica’s operating performance.
The supplied average analyst target is C$606.10. It’s separate from the October 28 opinion and doesn’t explain its case.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
